Pharma News

A new weapon has been discovered in the fight against Parkinson's disease after scientists worked out a way to get rid of toxic clumps of protein in the brain.

In addition to China, LENVIMA is approved for use in the treatment of HCC in Japan, the United States, Europe, and other countries in Asia and around the worldJapan's Eisai announced that its Chin...

Theragen ETEX said it has signed a technology transfer agreement related to TEJ-1704, an orally administrable derivative candidate for Radicut Injection, a Lou Gehrig's Disease treatment, with J2H...

FRANKFURT (Reuters) - Germany’s health minister Jens Spahn has called for faster adoption of cheaper copies of biotech drugs to treat cancer and autoimmune diseases to reign in rising public...

LONDON (Reuters) - Pfizer lost the final round in a long-running patent battle in Britain on Wednesday after the country’s highest court ruled against it in a case involving its $5 billion-a...

Basel, November 11, 2018 - Novartis announced today results of the landmark PIONEER-HF trial showing that in-hospital initiation of Entresto tablets provided superior benefit compared to enalapril-a...

AstraZeneca has agreed to sell US rights to Synagis (palivizumab) used for the prevention of serious lower respiratory tract infection (LRTI) caused by respiratory syncytial virus (...

EMD Serono wants to know what’s on the minds of multiple sclerosis patients and their loved ones.

Last month, AstraZeneca and Merck’s Lynparza posted big-time ovarian cancer data, and regulators are taking note.

Antimicrobial resistance is a major threat to health and human development, affecting our ability to treat a range of infections.

AstraZeneca today announced positive full results from the DECLARE-TIMI 58 cardiovascular (CV) outcomes trial (CVOT) for Farxiga (dapagliflozin).

Investigational Medicinal Product (IMP) Gammora is a synthetic peptide compound derived from the HIV enzyme integrase, which is responsible for inserting the virus's genetic material into ...